Cleared Traditional

K171144 - Medifine Pen Needle 3 Bevel, Medifine Pen Needle Quinta 5 Bevel

K171144 is an FDA 510(k) clearance for Medifine Pen Needle 3 Bevel, manufactured by Medbio, LLC. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 146-day FDA review.

K171144 · Medbio, LLC · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2017
Decision
146d
Days
Class 2
Risk

K171144 is an FDA 510(k) clearance for the Medifine Pen Needle 3 Bevel, Medifine Pen Needle Quinta 5 Bevel. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Medbio, LLC (Cooper City, US). The FDA issued a Cleared decision on September 12, 2017 after a review of 146 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K171144

510(k) Number K171144 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 2017
Decision Date September 12, 2017
Days to Decision 146 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 129d · This submission: 146d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

LK Consulting Group USA, Inc.
Priscilla Chung

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 586
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K171144.
DropSafe Safety Pen Needle
K170988 · Htl-Strefa S.A · Dec 2017
Safety Blood Collection Device for Single Use
K170276 · Gemtier Medical (Shanghai), Inc. · Dec 2017
Clickfine Pen Needle, Penfine Classic Pen Needle
K171984 · Ypsomed AG · Oct 2017
Mini Needle
K170768 · Ocuject, LLC · Jul 2017
Common Type Insulin Pen Needle, Safety Type Insulin Pen Needle
K161950 · Promisemed Hangzhou Meditech Co., Ltd. · May 2017
Safety Blood Collection Set
K163093 · Jiangsu Shenli Medical Production Co., Ltd. · Mar 2017